SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
SI-BONE (Nasdaq: SIBN) will report first-quarter 2026 financial results after market close on Monday, May 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SI-BONE (Nasdaq: SIBN) will report first-quarter 2026 financial results after market close on Monday, May 11, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET the same day.
Investors can register to listen via the provided webcast link and access live audio and a replay from the company’s Investors website; the webcast replay will remain available for at least 90 days.
Details
News Market Reaction – SIBN
On Apr 21, the first trading day after this news, SIBN closed 3.49% below the previous close.
Data tracked by StockTitan Argus for the Apr 21 session.
Key Figures
- Earnings release date
- May 11, 2026
- First-quarter 2026 financial results after market close
- Conference call time PT
- 1:30 p.m.
- Start time in Pacific Time
- Conference call time ET
- 4:30 p.m.
- Start time in Eastern Time
- Webcast replay duration
- 90 days
- Minimum archive period on Investors website
Previous Earnings date Reports
-
Scheduled Q4 and FY 2025 earnings release and webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the first quarter of 2026 after market close on Monday, May 11, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/vde24u4q. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in performing a total of over 140,000 procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including four randomized controlled trials and over 180 peer reviewed publications.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.